Update: 03.09.2024
Last week: 34 week 2024 (19.08.2024 - 25.08.2024)
Last full month: July 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 282 | 5.4% | 13.2% | -0.3 | 15 300 603 | 4.4% | 9.2% | -0.3 | 7.8% |
| MoM | 33 561 | 12.5% | 13.2% | 1.4 | 64 687 077 | 4.5% | 9.7% | 0.5 | 0.2% |
| YTD | 248 362 | 21.1% | 11.6% | 2.8 | 528 354 505 | 39.0% | 9.4% | 2 | -8.2% |
| MAT | 384 196 | 24.7% | 10.9% | 2.2 | 805 139 245 | 42.0% | 9.0% | 1.6 | -0.3% |
| BRAINMAX | |||||||||
| WoW | 1 280 | -1.2% | 100.0% | 0 | 4 883 026 | 0.5% | 100.0% | 0 | -1.2% |
| MoM | 5 212 | 11.0% | 100.0% | 0 | 19 612 893 | 12.5% | 100.0% | 0 | 11.2% |
| YTD | 36 663 | 39.8% | 100.0% | 0 | 134 927 469 | 51.8% | 100.0% | 0 | 39.8% |
| MAT | 57 094 | 58.4% | 100.0% | 0 | 207 012 342 | 72.0% | 100.0% | 0 | 58.4% |
| GOLDLINE PLUS | |||||||||
| WoW | 15 929 | 3.9% | 45.4% | -0.5 | 50 165 988 | 5.6% | 37.6% | -0.6 | 5.0% |
| MoM | 68 010 | -10.6% | 46.4% | 0.7 | 212 403 736 | -10.0% | 38.3% | 0.8 | -12.0% |
| YTD | 570 763 | -4.7% | 45.0% | 0.7 | 1 797 053 166 | -1.8% | 36.8% | -2.7 | -6.2% |
| MAT | 840 743 | 1.4% | 45.4% | 0.9 | 2 659 403 053 | 6.8% | 37.8% | -1.7 | -0.7% |
| MIGRENIUM | |||||||||
| WoW | 12 361 | 1.8% | 0.5% | 0 | 4 090 617 | 1.1% | 0.7% | 0 | 5.7% |
| MoM | 45 770 | -3.4% | 0.5% | -0.1 | 15 433 925 | -1.3% | 0.6% | -0.1 | 11.3% |
| YTD | 400 113 | -8.2% | 0.5% | -0.1 | 124 408 753 | 56.8% | 0.7% | 0.2 | 7.9% |
| MAT | 605 845 | -8.3% | 0.5% | -0.1 | 167 754 400 | 39.6% | 0.6% | 0.1 | 11.2% |
| MODELAX-N | |||||||||
| WoW | 26 169 | 5.9% | 19.4% | -0.3 | 12 264 995 | 5.6% | 12.9% | -0.1 | 7.5% |
| MoM | 102 999 | -20.7% | 19.3% | -6.2 | 48 116 412 | -16.9% | 13.0% | -4 | 4.9% |
| YTD | 985 957 | 32.9% | 22.7% | 4 | 426 461 368 | 82.3% | 14.6% | 4.2 | 9.3% |
| MAT | 1 411 829 | 51.6% | 21.3% | 5.2 | 575 355 995 | 93.1% | 13.2% | 4.1 | 14.8% |
| REDUXIN | |||||||||
| WoW | 11 466 | 6.0% | 32.7% | 0.3 | 59 486 660 | 8.4% | 44.5% | 0.4 | 5.0% |
| MoM | 48 170 | -9.4% | 32.8% | 1 | 247 736 086 | -11.8% | 44.6% | 0.1 | -12.0% |
| YTD | 417 381 | -8.4% | 32.9% | -0.8 | 2 229 275 676 | 13.3% | 45.7% | 3.2 | -6.2% |
| MAT | 599 777 | -5.1% | 32.4% | -1.5 | 3 134 760 818 | 16.8% | 44.6% | 1.9 | -0.7% |
| REDUXIN FORTE | |||||||||
| WoW | 3 471 | 12.3% | 9.9% | 0.6 | 14 409 881 | 12.4% | 10.8% | 0.5 | 5.0% |
| MoM | 13 691 | -8.3% | 9.3% | 0.4 | 57 980 483 | -10.1% | 10.4% | 0.2 | -12.0% |
| YTD | 112 707 | 0.2% | 8.9% | 0.6 | 487 123 534 | 13.1% | 10.0% | 0.7 | -6.2% |
| MAT | 166 206 | 9.3% | 9.0% | 0.8 | 709 843 928 | 21.6% | 10.1% | 0.8 | -0.7% |
| SALVISAR | |||||||||
| WoW | 9 617 | 4.4% | 1.2% | 0 | 4 099 625 | 4.8% | 1.1% | 0 | 5.2% |
| MoM | 34 936 | -11.1% | 1.1% | -0.2 | 15 667 203 | -7.6% | 1.1% | -0.1 | 2.1% |
| YTD | 338 048 | 2.2% | 1.3% | 0 | 138 019 281 | 27.8% | 1.2% | 0.1 | -1.6% |
| MAT | 505 580 | -10.6% | 1.3% | -0.2 | 193 786 387 | 2.1% | 1.1% | -0.2 | 2.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 248 362 | 21.1% | 11.6% | 2.8 | 528 354 505 | 39.0% | 9.4% | 2 | -8.2% |
| BRAINMAX | 36 663 | 39.8% | 100.0% | 0 | 134 927 469 | 51.8% | 100.0% | 0 | 39.8% |
| GOLDLINE PLUS | 570 763 | -4.7% | 45.0% | 0.7 | 1 797 053 166 | -1.8% | 36.8% | -2.7 | -6.2% |
| MIGRENIUM | 400 113 | -8.2% | 0.5% | -0.1 | 124 408 753 | 56.8% | 0.7% | 0.2 | 7.9% |
| MODELAX-N | 985 957 | 32.9% | 22.7% | 4 | 426 461 368 | 82.3% | 14.6% | 4.2 | 9.3% |
| REDUXIN CAPS | 417 381 | -8.4% | 32.9% | -0.8 | 2 229 275 676 | 13.3% | 45.7% | 3.2 | -6.2% |
| REDUXIN FORTE | 112 707 | 0.2% | 8.9% | 0.6 | 487 123 534 | 13.1% | 10.0% | 0.7 | -6.2% |
| SALVISAR | 338 048 | 2.2% | 1.3% | 0 | 138 019 281 | 27.8% | 1.2% | 0.1 | -1.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 384 196 | 24.7% | 10.9% | 2.2 | 805 139 245 | 42.0% | 9.0% | 1.6 | -0.3% |
| BRAINMAX | 57 094 | 58.4% | 100.0% | 0 | 207 012 342 | 72.0% | 100.0% | 0 | 58.4% |
| GOLDLINE PLUS | 840 743 | 1.4% | 45.4% | 0.9 | 2 659 403 053 | 6.8% | 37.8% | -1.7 | -0.7% |
| MIGRENIUM | 605 845 | -8.3% | 0.5% | -0.1 | 167 754 400 | 39.6% | 0.6% | 0.1 | 11.2% |
| MODELAX-N | 1 411 829 | 51.6% | 21.3% | 5.2 | 575 355 995 | 93.1% | 13.2% | 4.1 | 14.8% |
| REDUXIN CAPS | 599 777 | -5.1% | 32.4% | -1.5 | 3 134 760 818 | 16.8% | 44.6% | 1.9 | -0.7% |
| REDUXIN FORTE | 166 206 | 9.3% | 9.0% | 0.8 | 709 843 928 | 21.6% | 10.1% | 0.8 | -0.7% |
| SALVISAR | 505 580 | -10.6% | 1.3% | -0.2 | 193 786 387 | 2.1% | 1.1% | -0.2 | 2.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 282 | 5.4% | 13.2% | -0.3 | 15 300 603 | 4.4% | 9.2% | -0.3 | 7.8% |
| BRAINMAX | 1 280 | -1.2% | 100.0% | 0 | 4 883 026 | 0.5% | 100.0% | 0 | -1.2% |
| GOLDLINE PLUS | 15 929 | 3.9% | 45.4% | -0.5 | 50 165 988 | 5.6% | 37.6% | -0.6 | 5.0% |
| MIGRENIUM | 12 361 | 1.8% | 0.5% | 0 | 4 090 617 | 1.1% | 0.7% | 0 | 5.7% |
| MODELAX-N | 26 169 | 5.9% | 19.4% | -0.3 | 12 264 995 | 5.6% | 12.9% | -0.1 | 7.5% |
| REDUXIN CAPS | 11 466 | 6.0% | 32.7% | 0.3 | 59 486 660 | 8.4% | 44.5% | 0.4 | 5.0% |
| REDUXIN FORTE | 3 471 | 12.3% | 9.9% | 0.6 | 14 409 881 | 12.4% | 10.8% | 0.5 | 5.0% |
| SALVISAR | 9 617 | 4.4% | 1.2% | 0 | 4 099 625 | 4.8% | 1.1% | 0 | 5.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 33 561 | 12.5% | 13.2% | 1.4 | 64 687 077 | 4.5% | 9.7% | 0.5 | 0.2% |
| BRAINMAX | 5 212 | 11.0% | 100.0% | 0 | 19 612 893 | 12.5% | 100.0% | 0 | 11.2% |
| GOLDLINE PLUS | 68 010 | -10.6% | 46.4% | 0.7 | 212 403 736 | -10.0% | 38.3% | 0.8 | -12.0% |
| MIGRENIUM | 45 770 | -3.4% | 0.5% | -0.1 | 15 433 925 | -1.3% | 0.6% | -0.1 | 11.3% |
| MODELAX-N | 102 999 | -20.7% | 19.3% | -6.2 | 48 116 412 | -16.9% | 13.0% | -4 | 4.9% |
| REDUXIN CAPS | 48 170 | -9.4% | 32.8% | 1 | 247 736 086 | -11.8% | 44.6% | 0.1 | -12.0% |
| REDUXIN FORTE | 13 691 | -8.3% | 9.3% | 0.4 | 57 980 483 | -10.1% | 10.4% | 0.2 | -12.0% |
| SALVISAR | 34 936 | -11.1% | 1.1% | -0.2 | 15 667 203 | -7.6% | 1.1% | -0.1 | 2.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs